Breaking News, Collaborations & Alliances

RevolKa Signs Master Service Agreement with Daiichi Sankyo

Will create and deliver functional proteins in collaboration with Daiichi Sankyo by using its protein engineering platform technology.

Author Image

By: Charlie Sternberg

Associate Editor

RevolKa Ltd., a venture-backed biotech company providing a protein engineering technology platform, has signed a master service agreement with Daiichi Sankyo Co., Ltd., under which RevolKa will create and deliver highly functional proteins in collaboration with Daiichi Sankyo Co., Ltd. by using its proprietary protein engineering platform technology, called aiProtein   RevolKa’s proprietary technology, aiProtein is a directed protein evolution technology integrated with artificial intelligence...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters